Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to assess immune response and safety of various potencies of a measles, mumps, rubella, and varicella (MMRVNS) vaccines given to healthy children of 4 to 6 years of age.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05630846
Study type Interventional
Source GlaxoSmithKline
Contact
Status Active, not recruiting
Phase Phase 2
Start date December 14, 2022
Completion date October 15, 2024